Tata Chemicals Croissance future
Future contrôle des critères 3/6
Tata Chemicals devrait augmenter ses bénéfices et son chiffre d'affaires de 68.4% et de 7.6% par an respectivement. Le BPA devrait croître de de 66.7% par an. Le rendement des capitaux propres devrait être 5% dans 3 ans.
Informations clés
68.4%
Taux de croissance des bénéfices
66.7%
Taux de croissance du BPA
| Chemicals croissance des bénéfices | 22.9% |
| Taux de croissance des recettes | 7.6% |
| Rendement futur des capitaux propres | 5.0% |
| Couverture par les analystes | Good |
| Dernière mise à jour | 04 Nov 2024 |
Mises à jour récentes de la croissance future
Recent updates
Tata Chemicals (NSE:TATACHEM) Will Be Hoping To Turn Its Returns On Capital Around
Oct 14
Is Tata Chemicals (NSE:TATACHEM) Using Too Much Debt?
Sep 18What Tata Chemicals Limited's (NSE:TATACHEM) P/S Is Not Telling You
Jul 12Increases to CEO Compensation Might Be Put On Hold For Now at Tata Chemicals Limited (NSE:TATACHEM)
Jun 20Tata Chemicals (NSE:TATACHEM) Will Pay A Smaller Dividend Than Last Year
Jun 05Tata Chemicals' (NSE:TATACHEM) Dividend Will Be Reduced To ₹15.00
May 22Some May Be Optimistic About Tata Chemicals' (NSE:TATACHEM) Earnings
May 07Should You Investigate Tata Chemicals Limited (NSE:TATACHEM) At ₹1,102?
Apr 16Improved Earnings Required Before Tata Chemicals Limited (NSE:TATACHEM) Stock's 33% Jump Looks Justified
Mar 08Tata Chemicals Limited Just Missed EPS By 31%: Here's What Analysts Think Will Happen Next
Feb 08Here's Why Tata Chemicals (NSE:TATACHEM) Can Manage Its Debt Responsibly
Jan 19Earnings Working Against Tata Chemicals Limited's (NSE:TATACHEM) Share Price
Dec 27Here's Why Tata Chemicals (NSE:TATACHEM) Can Manage Its Debt Responsibly
Sep 29Is Tata Chemicals Limited (NSE:TATACHEM) Potentially Undervalued?
Sep 08Tata Chemicals (NSE:TATACHEM) Is Increasing Its Dividend To ₹17.50
Jun 02Tata Chemicals (NSE:TATACHEM) Is Increasing Its Dividend To ₹17.50
May 19What Is Tata Chemicals Limited's (NSE:TATACHEM) Share Price Doing?
May 05At ₹955, Is Tata Chemicals Limited (NSE:TATACHEM) Worth Looking At Closely?
Jan 31Is Tata Chemicals (NSE:TATACHEM) A Risky Investment?
Dec 26Is Now The Time To Look At Buying Tata Chemicals Limited (NSE:TATACHEM)?
Sep 20We Think Tata Chemicals (NSE:TATACHEM) Can Stay On Top Of Its Debt
Aug 31Tata Chemicals' (NSE:TATACHEM) Shareholders Will Receive A Bigger Dividend Than Last Year
Jun 10Tata Chemicals (NSE:TATACHEM) Is Increasing Its Dividend To ₹12.50
May 17Tata Chemicals' (NSE:TATACHEM) Upcoming Dividend Will Be Larger Than Last Year's
May 03Tata Chemicals (NSE:TATACHEM) Has A Pretty Healthy Balance Sheet
Mar 03Is Tata Chemicals Limited (NSE:TATACHEM) Worth ₹915 Based On Its Intrinsic Value?
Feb 12Why Tata Chemicals Limited (NSE:TATACHEM) Could Be Worth Watching
Jan 26We Think Tata Chemicals (NSE:TATACHEM) Can Stay On Top Of Its Debt
Nov 23A Look At The Intrinsic Value Of Tata Chemicals Limited (NSE:TATACHEM)
Nov 04Is It Too Late To Consider Buying Tata Chemicals Limited (NSE:TATACHEM)?
Oct 18Is Tata Chemicals (NSE:TATACHEM) A Risky Investment?
Aug 03At ₹781, Is It Time To Put Tata Chemicals Limited (NSE:TATACHEM) On Your Watch List?
Jul 16Most Shareholders Will Probably Agree With Tata Chemicals Limited's (NSE:TATACHEM) CEO Compensation
Jun 25Is Tata Chemicals (NSE:TATACHEM) Using Too Much Debt?
Mar 24Tata Chemicals Limited's (NSE:TATACHEM) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Mar 08Prévisions de croissance des bénéfices et des revenus
| Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
|---|---|---|---|---|---|
| 3/31/2027 | 180,367 | 13,465 | 12,917 | 25,360 | 7 |
| 3/31/2026 | 166,338 | 11,487 | 12,205 | 22,898 | 8 |
| 3/31/2025 | 153,339 | 7,766 | 5,132 | 17,871 | 7 |
| 9/30/2024 | 149,930 | -3,400 | 2,300 | 21,960 | N/A |
| 6/30/2024 | 149,920 | -1,060 | N/A | N/A | N/A |
| 3/31/2024 | 154,210 | 2,820 | 11,820 | 30,160 | N/A |
| 12/31/2023 | 163,530 | 18,200 | N/A | N/A | N/A |
| 9/30/2023 | 167,710 | 20,600 | 15,820 | 32,430 | N/A |
| 6/30/2023 | 170,120 | 22,650 | N/A | N/A | N/A |
| 3/31/2023 | 167,890 | 23,350 | 13,930 | 29,710 | N/A |
| 12/31/2022 | 158,631 | 20,866 | N/A | N/A | N/A |
| 9/30/2022 | 148,561 | 19,896 | 7,255 | 21,643 | N/A |
| 6/30/2022 | 136,391 | 15,576 | N/A | N/A | N/A |
| 3/31/2022 | 126,220 | 12,530 | 3,680 | 16,450 | N/A |
| 12/31/2021 | 117,777 | 8,014 | N/A | N/A | N/A |
| 9/30/2021 | 112,422 | 6,613 | 1,200 | 13,576 | N/A |
| 6/30/2021 | 108,289 | 5,311 | N/A | N/A | N/A |
| 3/31/2021 | 101,998 | 2,564 | 7,954 | 20,373 | N/A |
| 12/31/2020 | 99,417 | 4,293 | N/A | N/A | N/A |
| 9/30/2020 | 99,590 | 4,355 | 8,305 | 20,129 | N/A |
| 6/30/2020 | 101,209 | 6,620 | N/A | N/A | N/A |
| 3/31/2020 | 103,568 | 8,066 | 5,807 | 17,801 | N/A |
| 12/31/2019 | 114,887 | 11,995 | N/A | N/A | N/A |
| 9/30/2019 | 115,717 | 11,916 | 7,012 | 19,734 | N/A |
| 6/30/2019 | 114,489 | 11,585 | N/A | N/A | N/A |
| 3/31/2019 | 103,367 | 9,319 | 5,000 | 15,823 | N/A |
| 12/31/2018 | 110,920 | 10,695 | N/A | N/A | N/A |
| 9/30/2018 | 108,328 | 13,955 | N/A | N/A | N/A |
| 6/30/2018 | 105,871 | 13,319 | N/A | N/A | N/A |
| 3/31/2018 | 102,697 | 12,906 | N/A | 18,692 | N/A |
| 12/31/2017 | 128,262 | 12,110 | N/A | N/A | N/A |
| 9/30/2017 | 123,813 | 8,930 | N/A | N/A | N/A |
| 6/30/2017 | 122,988 | 7,999 | N/A | N/A | N/A |
| 3/31/2017 | 103,461 | 8,796 | N/A | 35,308 | N/A |
| 12/31/2016 | 163,372 | 8,854 | N/A | N/A | N/A |
| 9/30/2016 | 168,402 | 8,292 | N/A | N/A | N/A |
| 6/30/2016 | 173,604 | 8,388 | N/A | N/A | N/A |
| 3/31/2016 | 148,729 | 6,964 | N/A | 23,319 | N/A |
| 12/31/2015 | 174,436 | 4,638 | N/A | N/A | N/A |
| 9/30/2015 | 176,230 | 5,719 | N/A | N/A | N/A |
| 6/30/2015 | 174,196 | 5,740 | N/A | N/A | N/A |
| 3/31/2015 | 172,045 | 5,965 | N/A | 12,736 | N/A |
| 12/31/2014 | 170,708 | -5,551 | N/A | N/A | N/A |
| 9/30/2014 | 169,026 | -8,091 | N/A | N/A | N/A |
| 6/30/2014 | 164,427 | -9,317 | N/A | N/A | N/A |
| 3/31/2014 | 158,854 | -10,320 | N/A | 23,376 | N/A |
| 12/31/2013 | 156,739 | 57 | N/A | N/A | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: TATACHEM devrait devenir rentable au cours des 3 prochaines années, ce qui est considéré comme une croissance plus rapide que le taux d'épargne ( 6.7% ).
Bénéfices vs marché: TATACHEM devrait devenir rentable au cours des 3 prochaines années, ce qui est considéré comme une croissance supérieure à la moyenne du marché.
Croissance élevée des bénéfices: TATACHEM devrait devenir rentable dans les 3 prochaines années.
Chiffre d'affaires vs marché: Le chiffre d'affaires de TATACHEM ( 7.6% par an) devrait croître plus lentement que le marché de Indian ( 10.5% par an).
Croissance élevée des revenus: Le chiffre d'affaires de TATACHEM ( 7.6% par an) devrait croître plus lentement que 20% par an.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Le retour sur capitaux propres de TATACHEM devrait être faible dans 3 ans ( 5 %).